Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_assertion type Assertion NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_head.
- NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_assertion description "[Furthermore, the apo E2 group with renal failure had significantly higher ratios of VLDL-(chol/TG) and VLDL-chol/TG (an index of remnants in plasma) than the apo E3/3 group with renal failure and the apo E2 and E3/3 groups with normoalbuminuria.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_provenance.
- NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_assertion evidence source_evidence_literature NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_provenance.
- NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_assertion SIO_000772 7980694 NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_provenance.
- NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_assertion wasDerivedFrom befree-20140225 NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_provenance.
- NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_assertion wasGeneratedBy ECO_0000203 NP618919.RASTCdrf5OsVALWIyp54cSDPScAUGPFCkTtOIVbfHMI6A130_provenance.